Professional development - Membership of the RCGP
Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more
Under proposals for a radical overhaul of healthcare in the capital, which the government could roll out across the UK, GPs will be encouraged to sell up and move into NHS-owned polyclinics, housing up to 10 practices.
In his report, 'Healthcare for London: a framework for action', published last week and commissioned by NHS London, the surgeon and junior health minister Professor Sir Ara Darzi describes current GP premises as 'often in cramped, converted residential spaces with little opportunity to expand'.
Polyclinics could house 25 GPs working alongside consultants. X-rays, ultrasound, blood tests and dialysis would all be provided, with hospitals concentrating on acute services.
Sir Ara hopes the first clinics will open by April 2009.
The report says polyclinics will offer 'extended opening hours across a wide range of services'.
APMS contractors would be welcome to bid if GP consortia were not interested in managing polyclinics.
NHS London said the capital was 'going to be a model for other areas' as they review primary care.
Londonwide LMCs secretary Dr Fay Wilson said: 'We're worried that they will do the downgrading hospitals bit without putting extra funds into primary care; that would leave us with a load of inefficient white elephants in London with GPs rattling around in pointless buildings.'
NHS London Report
Comment below and tell us what you think
Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more
Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more
Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more
Section 1 Definition and pathophysiology Read more
Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more
Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more
Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more
Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more
Comments
Only registered users may comment. Log in now or register for a free account.